title: Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia.
authors.forename: J D
authors.initials: JD
authors.lastname: Hines
authors.forename: J J
authors.initials: JJ
authors.lastname: Mazza
authors.forename: M M
authors.initials: MM
authors.lastname: Oken
authors.forename: D J
authors.initials: DJ
authors.lastname: Adelstein
authors.forename: A
authors.initials: A
authors.lastname: Keller
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Connell
mesh_terms: D000208:Acute Disease; D000677:Amsacrine / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000628:therapy; D011379:Prognosis
chemical_list: D000677:Amsacrine; D003561:Cytarabine